GGrantIndex
Sort

326,823 grants matching clinical trial

IMPAACT Leadership Group

$2,537,610
Sharon A Nachman · Johns Hopkins University · UM1 · FY2025 · AI

Mechanisms of Frustration and the Pathophysiology of Severe Irritability in Youth

$2,537,435
Ellen Leibenluft · National Institute Of Mental Health · ZIA · FY2021 · MH

A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?

$2,537,053
Christopher K Glass · University Of California, San Diego · P01 · FY2020 · HL

Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders

$2,536,937
Carlos Zarate · National Institute Of Mental Health · ZIA · FY2018 · MH

Experimental Therapy for Brain Tumors

$2,536,844
John H Sampson · Duke University · P01 · FY2020 · CA

Psychotherapy Development Research Center

$2,535,538
Kathleen M Carroll · Yale University · P50 · FY2015 · DA

Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)

$2,535,440
Lorenzo Leggio · National Institute On Drug Abuse · ZIA · FY2022 · DA

Molecular Transducers of Physical Activity and Health: NC Consortium Clinical Site

$2,535,367
William E Kraus · Duke University · U01 · FY2023 · AR

Dominantly Inherited Alzheimer Network Administrative Core

$2,535,326
Randall J Bateman · Washington University · U19 · FY2019 · AG

Washington University University of Texas Southwestern VCID Consortium Site

$2,535,125
Jin-Moo Lee · Washington University · UF1 · FY2021 · NS

Selection of Novel Therapies to Ablate Chemoresistant Myeloid Leukemia Stem Cell

$2,535,000
Monica L Guzman · Weill Medical Coll Of Cornell Univ · DP2 · FY2010 · OD

SPORE in Lymphoma

$2,534,934
Johns Hopkins University · P50 · FY2004 · CA

SARS-CoV adaptations through a Systems Biology Lens (SYBIL)

$2,534,738
Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2024 · AI

Precision Delivery and Imaging to Enhance Solid Tumor Therapy

$2,534,428
Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · P01 · FY2022 · CA

Carbohydrate-based Therapy for Lung Disease

$2,534,255
John V Fahy · University Of California, San Francisco · P01 · FY2016 · HL

SPORE IN BREAST CANCER

$2,534,107
Baylor College Of Medicine · P50 · FY2000 · CA

Neuroprotection Studies in PD: A Coordinating Center

$2,533,926
Karl D. Kieburtz · University Of Rochester · U01 · FY2010 · NS

Regulatory Affairs Support

$2,533,844
Julie Newhart · Leidos, Inc. · N01 · FY2014 · AI

Canadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network: Statistics and Data Management Core

$2,533,285
Janet Ellen Dancey · Queen'S University At Kingston · U10 · FY2024 · CA

Clinical Coordinating Center for the Acute to Chronic Pain Signatures Program

$2,533,120
Kathleen A Sluka · University Of Iowa · U24 · FY2022 · NS

NIDA Clinical Trials Network: Greater New York Node

$2,533,075
John P Rotrosen · New York University School Of Medicine · UG1 · FY2019 · DA

Maternal and infant immunization to eliminate breast milk transmission of HIV-1

$2,532,602
Sallie R. Permar · Duke University · P01 · FY2016 · AI

SPORE IN PROSTATE CANCER

$2,532,522
William George Nelson · Johns Hopkins University · P50 · FY2007 · CA

(EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank

$2,532,382
Kathleen Nicol · Research Inst Nationwide Children'S Hosp · U24 · FY2020 · CA

(EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank

$2,532,382
Kathleen Nicol · Research Inst Nationwide Children'S Hosp · U24 · FY2021 · CA